Evidence map›Paper›PMID 41315890›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

A Quantum Framework for Protein Binding-Site Structure Prediction on Utility-Level Quantum Processors.

Yuqi Zhang, Yuxin Yang, William Martin, Kingsten Lin, Zixu Wang, Cheng-Chang Lu, Weiwen Jiang, Ruth Nussinov, Joseph Loscalzo, Qiang Guan and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuqi ZhangDepartment of Computer Science, Kent State University, Kent, OH, 44240, USA.
Yuxin YangCleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, 44195, USA.
William MartinCleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, 44195, USA.
Kingsten LinCleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, 44195, USA.
Zixu WangCleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, 44195, USA.
Cheng-Chang LuQradle Inc., Kent, OH, 44240, USA.
Weiwen JiangDepartment of Electrical and Computer Engineering, George Mason University, Fairfax, VA, 22030, USA.
Ruth NussinovComputational Structural Biology Section, National Cancer Institute, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, Frederick, MD, 21701, USA.
Joseph LoscalzoDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Qiang GuanDepartment of Computer Science, Kent State University, Kent, OH, 44240, USA.
Feixiong ChengCleveland Clinic Genome Center, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH, 44195, USA.ORCID https://orcid.org/0000-0002-1736-2847

Funding

Endophenotype Network-based Approaches to Prediction and Population-based Validation of In Silico Drug Repurposing for Alzheimer's DiseaseR01AG066707 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI Feixiong Cheng · 2020 to 2026
$4.9M
L-2-Hydroxyglutarate and Metabolic Remodeling in HypoxiaR01HL155107 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Joseph Loscalzo · 2021 to 2026
$4.1M
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimer’s DiseaseR01AG076448 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI Feixiong Cheng, Li Gan · 2022 to 2026
$4.0M
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics DiscoveryU01AG073323 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI BEKRIS, LYNN, CHENG, FEIXIONG · 2021 to 2025
$4.0M
Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle CellsR01HL166137 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Joseph Loscalzo · 2023 to 2026
$2.8M
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug RepurposingRF1AG082211 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CHENG, FEIXIONG, PIEPER, ANDREW A · 2023 to 2023
$2.4M
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approachesR01AG082118 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI BONAKDARPOUR, BORNA, CHENG, FEIXIONG · 2023 to 2025
$2.4M
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related DementiaRF1NS133812 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI BROWN, JONATHAN MARK, CHENG, FEIXIONG · 2023 to 2023
$2.3M
Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s DiseaseR01AG084250 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI Feixiong Cheng, Justin D. Lathia · 2023 to 2026
$2.2M
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and LongevityR33AG083003 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI Feixiong Cheng · 2025 to 2026
$1.1M
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and LongevityR21AG083003 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI CHENG, FEIXIONG · 2023 to 2023
$483k
Alzheimer's Association ALZDISCOVERY-1051936American Heart Association AHA24MERIT118544d7American Heart Association-American Stroke Association 957729EU Horizon 2021 101057619National Cancer Institute, National Institutes of Health HHSN261201500003lNational Heart, Lung, and Blood Institute (NHLBI) R01HL155107National Heart, Lung, and Blood Institute (NHLBI) R01HL166137National Science Foundation NSF2230111National Science Foundation NSF2238734National Science Foundation NSF2311950National Science Foundation NSF2513432NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INHLBI NIH HHS R01 HL155107NHLBI NIH HHS R01 HL166137NIA NIH HHS R01 AG066707NIA NIH HHS R01AG066707NIA NIH HHS R01 AG076448NIA NIH HHS R01AG076448NIA NIH HHS R01 AG082118NIA NIH HHS R01AG082118NIA NIH HHS R01 AG084250NIA NIH HHS R01AG084250NIA NIH HHS R21 AG083003NIA NIH HHS R21AG083003NIA NIH HHS R33 AG083003NIA NIH HHS R33AG083003NIA NIH HHS RF1 AG082211NIA NIH HHS RF1AG082211NIA NIH HHS U01 AG073323NIA NIH HHS U01AG073323NINDS NIH HHS RF1 NS133812NINDS NIH HHS RF1NS133812
6 · The paper itself

Abstract

Accurate prediction of protein active-site structures remains a central challenge in structural biology, especially for short and flexible peptide fragments where conventional and simulation-based methods often fail. Here, we present a quantum computing framework designed for utility-level quantum processors to address this problem. Starting from an amino acid sequence, we cast structure prediction as a ground-state energy minimization task using the Variational Quantum Eigensolver (VQE). Amino acid connectivity is represented on a tetrahedral lattice, and steric, geometric, and chirality constraints are encoded into a problem-specific Hamiltonian expressed as sparse Pauli operators. A two-stage architecture separates energy estimation from measurement decoding, enabling noise mitigation under realistic device conditions. We evaluate the method on 23 real protein fragments from the PDBbind dataset and 7 fragments from therapeutically relevant proteins, executing all experiments on the IBM-Cleveland Clinic quantum processor. Structural predictions are benchmarked against AlphaFold3 (AF3) and classical simulation-based approaches using identical postprocessing and docking procedures. Our quantum framework outperforms both AF3 and classical baselines in Root-Mean-Square Deviation (RMSD) and docking efficacy, demonstrating a practical end-to-end pipeline for biologically relevant structure prediction on real quantum hardware and highlighting its engineering feasibility for near-term quantum devices.

Indexed as

ProteinsQuantum TheoryBinding SitesProtein BindingProtein ConformationProteinsprotein structure predictionquantum computingquantum structural biologyreal quantum processors

Identifiers

PMID41315890
PMCPMC12948255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.